Overview

Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.
Phase:
Phase 4
Details
Lead Sponsor:
Tottori University Hospital
Treatments:
Furosemide
Insulin
Spironolactone